A Trial of AXS-05 in Patients With Major Depressive Disorder (GEMINI Trial)
Recruiting in Palo Alto (17 mi)
+41 other locations
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Axsome Therapeutics, Inc.
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of AXS-05 in patients with major depressive disorder (MDD).
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: AXS-05Experimental Treatment1 Intervention
AXS-05 (bupropion and dextromethorphan) oral tablets
Group II: PlaceboPlacebo Group1 Intervention
Placebo oral tablets to match AXS-05
AXS-05 is already approved in United States for the following indications:
🇺🇸 Approved in United States as Auvelity for:
- Major depressive disorder
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Clinical Research SiteGarden Grove, CA
Clinical Research SitePhiladelphia, PA
Clinical Research SiteHickory, NC
Clinical Research SiteNorth Miami, FL
More Trial Locations
Loading ...
Who is running the clinical trial?
Axsome Therapeutics, Inc.Lead Sponsor